Abstract
The concept of hardware fusion between positron emission tomography (PET) and computed tomography (CT) has only been introduced commercially in the last 4 years. The advantages of this combined technique over PET alone have become obvious. There is increasing evidence to suggest that PET/CT adds complementary information in staging, re-staging and follow-up in oncology patients, leading to changes in management plans. The present paper is a review of the strengths, weaknesses, current evidence and future directions of this technique.
Original language | English |
---|---|
Pages (from-to) | 1143-1155 |
Number of pages | 13 |
Journal | Clinical Radiology |
Volume | 60 |
Issue number | 11 |
DOIs | |
Publication status | Published - Nov 2005 |